{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T18:21:05Z","timestamp":1770834065974,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Natural Science Foundation of Chongqing municipality","award":["CSTB2023NSCQ-MSX0858"],"award-info":[{"award-number":["CSTB2023NSCQ-MSX0858"]}]},{"name":"Natural Science Foundation of Chongqing municipality","award":["CSTB2024NSCQ-MSX0217"],"award-info":[{"award-number":["CSTB2024NSCQ-MSX0217"]}]},{"name":"Natural Science Foundation of Chongqing municipality","award":["CSTB2024NSCQ-MSX0334"],"award-info":[{"award-number":["CSTB2024NSCQ-MSX0334"]}]},{"name":"Natural Science Foundation of Chongqing municipality","award":["CSTB2024NSCQ-MSX0760"],"award-info":[{"award-number":["CSTB2024NSCQ-MSX0760"]}]},{"name":"Natural Science Foundation of Chongqing municipality","award":["CSTB2023NSCQ-MSX0787"],"award-info":[{"award-number":["CSTB2023NSCQ-MSX0787"]}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","award":["2023CDJYGRH-YB04"],"award-info":[{"award-number":["2023CDJYGRH-YB04"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Chongqing Medical Research Project of Combination of Science and Medicine","award":["2024MSXM171"],"award-info":[{"award-number":["2024MSXM171"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-026-02160-2","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T10:06:10Z","timestamp":1768557970000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Early prediction of pathologic complete response to neoadjuvant chemotherapy based on longitudinal total choline of MR spectroscopy in patients with breast cancer"],"prefix":"10.1186","volume":"26","author":[{"given":"Shuling","family":"Liu","sequence":"first","affiliation":[]},{"given":"Xiaoxia","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Fujie","family":"Jiang","sequence":"additional","affiliation":[]},{"given":"Sun","family":"Tang","sequence":"additional","affiliation":[]},{"given":"Ying","family":"Cao","sequence":"additional","affiliation":[]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Huifang","family":"Chen","sequence":"additional","affiliation":[]},{"given":"Xiangfei","family":"Zeng","sequence":"additional","affiliation":[]},{"given":"Yao","family":"Huang","sequence":"additional","affiliation":[]},{"given":"Lan","family":"Li","sequence":"additional","affiliation":[]},{"given":"Renzhi","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Jiuquan","family":"Zhang","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"issue":"1","key":"2160_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"R Siegel","year":"2020","unstructured":"Siegel R, Miller K, Jemal A. Cancer statistics, 2020. Cancer J Clin. 2020;70(1):7\u201330.","journal-title":"Cancer J Clin"},{"issue":"6","key":"2160_CR2","doi-asserted-by":"publisher","first-page":"691","DOI":"10.6004\/jnccn.2022.0030","volume":"20","author":"W Gradishar","year":"2022","unstructured":"Gradishar W, Moran M, Abraham J, Aft R, Agnese D, Allison K, Anderson B, Burstein H, Chew H, Dang C, et al. Breast Cancer, version 3.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Network: JNCCN. 2022;20(6):691\u2013722.","journal-title":"J Natl Compr Cancer Network: JNCCN"},{"issue":"6","key":"2160_CR3","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jamcollsurg.2015.02.011","volume":"220","author":"B Killelea","year":"2015","unstructured":"Killelea B, Yang V, Mougalian S, Horowitz N, Pusztai L, Chagpar A, Lannin D. Neoadjuvant chemotherapy for breast cancer increases the rate of breast conservation: results from the National cancer database. J Am Coll Surg. 2015;220(6):1063\u20139.","journal-title":"J Am Coll Surg"},{"key":"2160_CR4","doi-asserted-by":"publisher","first-page":"e570","DOI":"10.5114\/pjr.2019.92282","volume":"84","author":"D Bayoumi","year":"2019","unstructured":"Bayoumi D, Zaky M, Ibrahim D, Abdallah A, Abouelkhair K. The additive role of H-magnetic resonance spectroscopic imaging to ensure pathological complete response after neoadjuvant chemotherapy in breast cancer patients. Pol J Radiol. 2019;84:e570\u201380.","journal-title":"Pol J Radiol"},{"issue":"12","key":"2160_CR5","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1158\/1078-0432.CCR-19-3492","volume":"26","author":"LM Spring","year":"2020","unstructured":"Spring LM, Fell G, Arfe A, Sharma C, Greenup R, Reynolds KL, Smith BL, Alexander B, Moy B, Isakoff SJ, et al. Pathologic complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and survival: A comprehensive Meta-analysis. Clin Cancer Res. 2020;26(12):2838\u201348.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"2160_CR6","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1148\/radiol.2018172171","volume":"287","author":"K Pinker","year":"2018","unstructured":"Pinker K, Chin J, Melsaether A, Morris E, Moy L. Precision medicine and radiogenomics in breast cancer: new approaches toward diagnosis and treatment. Radiology. 2018;287(3):732\u201347.","journal-title":"Radiology"},{"issue":"4","key":"2160_CR7","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/jum.14953","volume":"38","author":"AIUM\/IUGA Practice Parameter for the Performance of Urogynecological Ultrasound Examinations","year":"2019","unstructured":"AIUM\/IUGA Practice Parameter for the Performance of Urogynecological Ultrasound Examinations. Developed in collaboration with the ACR, the AUGS, the AUA, and the SRU. J Ultrasound Medicine: Official J Am Inst Ultrasound Med. 2019;38(4):851\u201364.","journal-title":"J Ultrasound Medicine: Official J Am Inst Ultrasound Med"},{"issue":"1","key":"2160_CR8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/RCT.0000000000000647","volume":"42","author":"J Zhou","year":"2018","unstructured":"Zhou J, Qiao P, Zhang H, Li G, Jiang Z. Predicting neoadjuvant chemotherapy in nonconcentric shrinkage pattern of breast cancer using 1H-Magnetic resonance spectroscopic imaging. J Comput Assist Tomogr. 2018;42(1):12\u20138.","journal-title":"J Comput Assist Tomogr"},{"issue":"5","key":"2160_CR9","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrc3038","volume":"11","author":"W Koppenol","year":"2011","unstructured":"Koppenol W, Bounds P, Dang C. Otto warburg\u2019s contributions to current concepts of cancer metabolism. Nat Rev Cancer. 2011;11(5):325\u201337.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2160_CR10","first-page":"80","volume":"59","author":"E Aboagye","year":"1999","unstructured":"Aboagye E, Bhujwalla Z. Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Res. 1999;59(1):80\u20134.","journal-title":"Cancer Res"},{"issue":"6","key":"2160_CR11","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.1007\/s00330-020-06678-z","volume":"30","author":"C Sodano","year":"2020","unstructured":"Sodano C, Clauser P, Dietzel M, Kapetas P, Pinker K, Helbich T, Gussew A, Baltzer P. Clinical relevance of total choline (tCho) quantification in suspicious lesions on multiparametric breast MRI. Eur Radiol. 2020;30(6):3371\u201382.","journal-title":"Eur Radiol"},{"key":"2160_CR12","doi-asserted-by":"publisher","first-page":"610354","DOI":"10.3389\/fonc.2021.610354","volume":"11","author":"N Prvulovic Bunovic","year":"2021","unstructured":"Prvulovic Bunovic N, Sveljo O, Kozic D, Boban J. Is elevated choline on magnetic resonance spectroscopy a reliable marker of breast lesion malignancy? Front Oncol. 2021;11:610354.","journal-title":"Front Oncol"},{"issue":"1","key":"2160_CR13","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12929-021-00750-6","volume":"28","author":"N Gholizadeh","year":"2021","unstructured":"Gholizadeh N, Greer P, Simpson J, Goodwin J, Fu C, Lau P, Siddique S, Heerschap A, Ramadan S. Diagnosis of transition zone prostate cancer by multiparametric MRI: added value of MR spectroscopic imaging with sLASER volume selection. J Biomed Sci. 2021;28(1):54.","journal-title":"J Biomed Sci"},{"key":"2160_CR14","doi-asserted-by":"publisher","first-page":"153303382110368","DOI":"10.1177\/15330338211036852","volume":"20","author":"R Liao","year":"2021","unstructured":"Liao R, Zhang D, Li X, Ma J, Yu J, Yang C, Xiong H, Zhou B, Huang X, Tang Z. A preliminary study on the diagnostic efficacy of proton magnetic resonance spectroscopy at 3.0T in rabbit with VX2 liver tumor. Technol Cancer Res Treat. 2021;20:15330338211036852.","journal-title":"Technol Cancer Res Treat"},{"issue":"4","key":"2160_CR15","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/jmri.22118","volume":"31","author":"M Tozaki","year":"2010","unstructured":"Tozaki M, Sakamoto M, Oyama Y, Maruyama K, Fukuma E. Predicting pathological response to neoadjuvant chemotherapy in breast cancer with quantitative 1H MR spectroscopy using the external standard method. J Magn Reson Imaging: JMRI. 2010;31(4):895\u2013902.","journal-title":"J Magn Reson Imaging: JMRI"},{"issue":"1","key":"2160_CR16","first-page":"39","volume":"2","author":"Y Murata","year":"2009","unstructured":"Murata Y, Hamada N, Kubota K, Miyatake K, Tadokoro M, Kataoka Y, Ue H, Tsuzuki K, Kariya S, Nishioka A, et al. Choline by magnetic spectroscopy and dynamic contrast enhancement curve by magnetic resonance imaging in neoadjuvant chemotherapy for invasive breast cancer. Mol Med Rep. 2009;2(1):39\u201343.","journal-title":"Mol Med Rep"},{"issue":"2","key":"2160_CR17","doi-asserted-by":"publisher","first-page":"118","DOI":"10.6004\/jnccn.2019.0009","volume":"17","author":"M Goetz","year":"2019","unstructured":"Goetz M, Gradishar W, Anderson B, Abraham J, Aft R, Allison K, Blair S, Burstein H, Dang C, Elias A, et al. NCCN guidelines insights: breast Cancer, version 3.2018. J Natl Compr Cancer Network: JNCCN. 2019;17(2):118\u201326.","journal-title":"J Natl Compr Cancer Network: JNCCN"},{"key":"2160_CR18","unstructured":"Goldhirsch A, Winer EP, Coates AS, Gelber RD, Piccart-Gebhart M, Th\u00fcrlimann B, Senn HJ; Panel members. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer 2013. Ann Oncol. 2013;24(9)."},{"issue":"31","key":"2160_CR19","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","volume":"31","author":"AC Wolff","year":"2013","unstructured":"Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH, Allred DC, Bartlett JM, Bilous M, Fitzgibbons P, et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American society of clinical Oncology\/College of American pathologists clinical practice guideline update. J Clin Oncol. 2013;31(31):3997\u20134013.","journal-title":"J Clin Oncol"},{"issue":"16","key":"2160_CR20","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","volume":"28","author":"ME Hammond","year":"2010","unstructured":"Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M, et al. American society of clinical Oncology\/College of American pathologists guideline recommendations for immunohistochemical testing of Estrogen and progesterone receptors in breast cancer. J Clin Oncol. 2010;28(16):2784\u201395.","journal-title":"J Clin Oncol"},{"issue":"12","key":"2160_CR21","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1158\/1078-0432.CCR-18-3190","volume":"25","author":"Z Liu","year":"2019","unstructured":"Liu Z, Li Z, Qu J, Zhang R, Zhou X, Li L, Sun K, Tang Z, Jiang H, Li H, et al. Radiomics of multiparametric MRI for pretreatment prediction of pathologic complete response to neoadjuvant chemotherapy in breast cancer: A multicenter study. Clin Cancer Research: Official J Am Association Cancer Res. 2019;25(12):3538\u201347.","journal-title":"Clin Cancer Research: Official J Am Association Cancer Res"},{"issue":"3","key":"2160_CR22","doi-asserted-by":"publisher","first-page":"310","DOI":"10.6004\/jnccn.2018.0012","volume":"16","author":"W Gradishar","year":"2018","unstructured":"Gradishar W, Anderson B, Balassanian R, Blair S, Burstein H, Cyr A, Elias A, Farrar W, Forero A, Giordano S, et al. Breast Cancer, version 4.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Network: JNCCN. 2018;16(3):310\u201320.","journal-title":"J Natl Compr Cancer Network: JNCCN"},{"issue":"2","key":"2160_CR23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/jmri.20646","volume":"24","author":"M Kumar","year":"2006","unstructured":"Kumar M, Jagannathan N, Seenu V, Dwivedi S, Julka P, Rath G. Monitoring the therapeutic response of locally advanced breast cancer patients: sequential in vivo proton MR spectroscopy study. J Magn Reson Imaging: JMRI. 2006;24(2):325\u201332.","journal-title":"J Magn Reson Imaging: JMRI"},{"issue":"8","key":"2160_CR24","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1054\/bjoc.2000.1711","volume":"84","author":"N Jagannathan","year":"2001","unstructured":"Jagannathan N, Kumar M, Seenu V, Coshic O, Dwivedi S, Julka P, Srivastava A, Rath G. Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Br J Cancer. 2001;84(8):1016\u201322.","journal-title":"Br J Cancer"},{"issue":"38","key":"2160_CR25","doi-asserted-by":"publisher","first-page":"63405","DOI":"10.18632\/oncotarget.18822","volume":"8","author":"J Choi","year":"2017","unstructured":"Choi J, Yoon D, Koo J, Kim S, Park V, Kim E, Kim S, Kim M. Magnetic resonance metabolic profiling of Estrogen receptor-positive breast cancer: correlation with currently used molecular markers. Oncotarget. 2017;8(38):63405\u201316.","journal-title":"Oncotarget"},{"issue":"1","key":"2160_CR26","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/nbm.1217","volume":"22","author":"I Haddadin","year":"2009","unstructured":"Haddadin I, McIntosh A, Meisamy S, Corum C, Styczynski Snyder A, Powell N, Nelson M, Yee D, Garwood M, Bolan P. Metabolite quantification and high-field MRS in breast cancer. NMR Biomed. 2009;22(1):65\u201376.","journal-title":"NMR Biomed"},{"issue":"4","key":"2160_CR27","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1002\/jmri.26042","volume":"48","author":"S Drisis","year":"2018","unstructured":"Drisis S, Flamen P, Ignatiadis M, Metens T, Chao S, Chintinne M, Lemort M. Total choline quantification measured by 1H MR spectroscopy as early predictor of response after neoadjuvant treatment for locally advanced breast cancer: the impact of immunohistochemical status. J Magn Reson Imaging: JMRI. 2018;48(4):982\u201393.","journal-title":"J Magn Reson Imaging: JMRI"},{"issue":"12","key":"2160_CR28","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1097\/RLI.0000000000000597","volume":"54","author":"F Galati","year":"2019","unstructured":"Galati F, Luciani M, Caramanico C, Moffa G, Catalano C, Pediconi F. Breast magnetic resonance spectroscopy at 3 T in Biopsy-Proven breast cancers: does choline peak correlate with prognostic factors? Invest Radiol. 2019;54(12):767\u201373.","journal-title":"Invest Radiol"},{"issue":"3","key":"2160_CR29","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/nbm.1436","volume":"23","author":"K Danishad","year":"2010","unstructured":"Danishad K, Sharma U, Sah R, Seenu V, Parshad R, Jagannathan N. Assessment of therapeutic response of locally advanced breast cancer (LABC) patients undergoing neoadjuvant chemotherapy (NACT) monitored using sequential magnetic resonance spectroscopic imaging (MRSI). NMR Biomed. 2010;23(3):233\u201341.","journal-title":"NMR Biomed"},{"issue":"5","key":"2160_CR30","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s12032-015-0603-1","volume":"32","author":"X Wang","year":"2015","unstructured":"Wang X, Wang X, Song H, Chen L. 1H-MRS evaluation of breast lesions by using total choline signal-to-noise ratio as an indicator of malignancy: a meta-analysis. Med Oncol (Northwood Lond Engl). 2015;32(5):160.","journal-title":"Med Oncol (Northwood Lond Engl)"},{"issue":"10","key":"2160_CR31","doi-asserted-by":"publisher","first-page":"e4032","DOI":"10.1002\/nbm.4032","volume":"32","author":"N Jagannathan","year":"2019","unstructured":"Jagannathan N. Application of in vivo MR methods in the study of breast cancer metabolism. NMR Biomed. 2019;32(10):e4032.","journal-title":"NMR Biomed"},{"key":"2160_CR32","doi-asserted-by":"crossref","unstructured":"Kristine G, Zaver MB, Sabrina MR. Choline metabolism in malignant transformation. Nat Rev Cancer. 2011;11(12).","DOI":"10.1038\/nrc3162"},{"key":"2160_CR33","doi-asserted-by":"crossref","unstructured":"Christoph T, Marija B, Nadia H, Michael G. St. Gallen\/Vienna 2021: a brief summary of the consensus discussion on customizing therapies for women with early breast cancer. Breast Care (Basel). 2021;16(2).","DOI":"10.1159\/000516114"},{"issue":"5","key":"2160_CR34","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s12282-013-0514-y","volume":"22","author":"H Baek","year":"2015","unstructured":"Baek H, Lee Y. Feasibility of MR spectroscopy for characterizing malignant breast lesions using a clinical 3-T scanner. Breast Cancer (Tokyo Japan). 2015;22(5):510\u20139.","journal-title":"Breast Cancer (Tokyo Japan)"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-026-02160-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02160-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02160-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T17:44:08Z","timestamp":1770831848000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12880-026-02160-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2160"],"URL":"https:\/\/doi.org\/10.1186\/s12880-026-02160-2","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"16 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We ensured that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki). This study was approved by the ethics committee of Chongqing University cancer Hospital, and informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"82"}}